| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
17.690 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
17.690 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
17.690 |
Evidence |
|
| RPS6KB1 |
IPI00216132 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
17.690 |
Evidence |
|
| RPS6KB1 |
IPI00216132 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
17.690 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
17.690 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
17.690 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
17.690 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
TNC |
TNC, HXB: Tenascin precursor |
17.690 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
17.690 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
17.690 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
17.690 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
17.690 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
17.690 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
17.690 |
Evidence |
|
| STMN1 |
STMN1, LAP18, OP18: Stathmin |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
17.690 |
Evidence |
|
| STMN1 |
STMN1, LAP18, OP18: Stathmin |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
17.690 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ITSN2 |
ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 |
17.690 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PKN3 |
PKN3, PKNBETA: Serine/threonine-protein kinase N3 |
17.690 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
17.690 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
CREBBP |
CREBBP, CBP: CREB-binding protein |
17.690 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
17.690 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
17.690 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
17.690 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
17.690 |
Evidence |
|